Author: Teoh, Kim-Tat; Siu, Yu-Lam; Chan, Wing-Lim; Schlüter, Marc A.; Liu, Chia-Jen; Peiris, J. S. Malik; Bruzzone, Roberto; Margolis, Benjamin; Nal, Béatrice
Title: The SARS Coronavirus E Protein Interacts with PALS1 and Alters Tight Junction Formation and Epithelial Morphogenesis Document date: 2010_11_15
ID: ufw13pjx_1
Snippet: The SARS coronavirus (SARS-CoV) is an enveloped virus with a positive single strand RNA genome, which has emerged in the human population during winter 2002–2003 causing an outbreak of severe acute respiratory infections with a 10% mortality rate (Peiris et al., 2004). The reasons for the severity of illness in SARS-CoV infected patients are still not clearly understood. The SARS-CoV mainly targets epithelial cells, the respiratory tract being .....
Document: The SARS coronavirus (SARS-CoV) is an enveloped virus with a positive single strand RNA genome, which has emerged in the human population during winter 2002–2003 causing an outbreak of severe acute respiratory infections with a 10% mortality rate (Peiris et al., 2004). The reasons for the severity of illness in SARS-CoV infected patients are still not clearly understood. The SARS-CoV mainly targets epithelial cells, the respiratory tract being the primary site of infection (Nicholls et al., 2003; Nicholls et al., 2006). One of the major pathological features of SARS-CoV infection is diffuse alveolar damage (DAD) of the human lung, more prominent in the terminal stage, with occasional extensive damage of the lung epithelium (Kuiken et al., 2003; Nicholls et al., 2003). Several hypotheses have been made to explain DAD, invoking either intrinsic cytopathic effect of the virus or dysfunction of the immune system (Chen and Subbarao, 2007; Perlman and Netland, 2009; Yoshikawa et al., 2009). Another clinical feature is the extrapulmonary dissemination of the virus with other organ dysfunction including lymphoid tissues, liver, intestine, and kidney (Farcas et al., 2005; Gu et al., 2005). One possibility is that viral proteins disrupt mucosal integrity by interfering with the regulation and maintenance of specialized epithelial functions, such as intercellular junctions and apicobasal polarity and, as a consequence, induce viral dissemination. In this line, recent studies using a recombinant virus lacking the SARS-Cov E gene suggest that E envelope protein is a virulence factor influencing replication level, virus dissemination, and pathogenicity of SARS-CoV in animal models (DeDiego et al., 2007; DeDiego et al., 2008). However, the molecular mechanism involving E in pathogenesis is not known. Interestingly, in vitro studies on monolayers of human airway epithelial cells have shown that morphology of cells was affected at late time points following infection (72 and 120 h) and suggested that cellular junctions and polarity were altered (Sims et al., 2005).
Search related documents:
Co phrase search for related documents- acute respiratory infection and animal model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- acute respiratory infection and clinical feature: 1, 2, 3, 4, 5, 6
- acute respiratory infection and cytopathic effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- acute respiratory infection and DAD diffuse alveolar damage: 1, 2, 3, 4, 5, 6, 7
- acute respiratory infection and diffuse alveolar damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory infection and dysfunction virus: 1, 2, 3, 4
- acute respiratory infection and enveloped virus: 1, 2, 3, 4, 5, 6
- acute respiratory infection and epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory infection and epithelial cell target: 1
- alveolar damage and animal model: 1, 2, 3, 4, 5, 6, 7, 8, 9
- alveolar damage and cell morphology: 1
- alveolar damage and clinical feature: 1, 2, 3, 4
- alveolar damage and cytopathic effect: 1, 2, 3, 4, 5, 6, 7, 8, 9
- alveolar damage and DAD diffuse alveolar damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- alveolar damage and diffuse alveolar damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- alveolar damage and enveloped virus: 1, 2
- alveolar damage and epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- alveolar damage and epithelial cell target: 1
- animal model and cell morphology: 1
Co phrase search for related documents, hyperlinks ordered by date